These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22155252)

  • 21. Blocking S1P interaction with S1P₁ receptor by a novel competitive S1P₁-selective antagonist inhibits angiogenesis.
    Fujii Y; Ueda Y; Ohtake H; Ono N; Takayama T; Nakazawa K; Igarashi Y; Goitsuka R
    Biochem Biophys Res Commun; 2012 Mar; 419(4):754-60. PubMed ID: 22387544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathway.
    Wu Y; He L; Zhang L; Chen J; Yi Z; Zhang J; Liu M; Pang X
    J Pharmacol Exp Ther; 2011 Nov; 339(2):403-11. PubMed ID: 21828260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wondonin, a novel compound, inhibits hypoxia-induced angiogenesis through hypoxia-inducible factor 1 alpha.
    Jun HO; Kim Y; Kwon YW; Hong SS; Kim KW; Shin J; Kim TY
    FEBS Lett; 2007 Oct; 581(25):4977-82. PubMed ID: 17919602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of lipoxin A(4) on CoCl(2)-induced angiogenesis and its possible mechanisms in human umbilical vein endothelial cells.
    Liu S; Wu P; Ye D; Huang Y; Zhou X; Li Y; Cai L
    Pharmacology; 2009; 84(1):17-23. PubMed ID: 19478549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
    Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-tumor and anti-angiogenic effects of Macrothelypteris viridifrons and its constituents by HPLC-DAD/MS analysis.
    Wei A; Zhou D; Ruan J; Cai Y; Xiong C; Wu G
    J Ethnopharmacol; 2012 Jan; 139(2):373-80. PubMed ID: 22123201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total alkaloids of Rubus alceifolius Poir shows anti-angiogenic activity in vivo and in vitro.
    Zhao J; Lin W; Zhuang Q; Zhong X; Cao Z; Hong Z; Peng J
    Integr Cancer Ther; 2014 Nov; 13(6):520-8. PubMed ID: 25148840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemokinins modulate endothelium function and promote angiogenesis through neurokinin-1 receptor.
    Song H; Yin W; Zeng Q; Jia H; Lin L; Liu X; Mu L; Wang R
    Int J Biochem Cell Biol; 2012 Sep; 44(9):1410-21. PubMed ID: 22554585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways.
    Pan R; Dai Y; Gao XH; Lu D; Xia YF
    Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis inhibition by the maleimide-based small molecule GNX-686.
    Nowak-Sliwinska P; Storto M; Cataudella T; Ballini JP; Gatz R; Giorgio M; van den Bergh H; Plyte S; Wagnières G
    Microvasc Res; 2012 Mar; 83(2):105-10. PubMed ID: 22056402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The saponin monomer of dwarf lilyturf tuber, DT-13, inhibits angiogenesis under hypoxia and normoxia via multi-targeting activity.
    Zhao R; Sun L; Lin S; Bai X; Yu B; Yuan S; Zhang L
    Oncol Rep; 2013 Apr; 29(4):1379-86. PubMed ID: 23404207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
    Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
    Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
    Morais C; Gobe G; Johnson DW; Healy H
    Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VEGF111b, a new member of VEGFxxxb isoforms and induced by mitomycin C, inhibits angiogenesis.
    Gu F; Li X; Kong J; Pan B; Sun M; Zheng L; Yao Y
    Biochem Biophys Res Commun; 2013 Nov; 441(1):18-24. PubMed ID: 24125722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noscapine inhibits hypoxia-mediated HIF-1alpha expression andangiogenesis in vitro: a novel function for an old drug.
    Newcomb EW; Lukyanov Y; Schnee T; Ali MA; Lan L; Zagzag D
    Int J Oncol; 2006 May; 28(5):1121-30. PubMed ID: 16596228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.